[Neonatal hyperammonemia].

J Jaeken; H Devlieger; M Evens; P Casaer; E Eggermont

Home/Archive/PubMed

PubMed · 6636106

[Neonatal hyperammonemia].

J Jaeken·H Devlieger·M Evens·P Casaer·E Eggermont

View original source ↗Export metadata ↓

Abstract

Experience with severe neonatal hyperammonaemia in the Newborn Intensive Care Unit of the Leuven University Hospital is reported and compared with the literature data. Among eleven patients seven presented with the transient neonatal hyperammonaemia-syndrome and four with a urea cycle defect. Prompt recognition of the transient neonatal hyperammonaemia syndrome is important because its prognosis is much better than that of the primary urea cycle defects presenting in the neonatal period.

Explore related subjects

Amino Acid Metabolism, Inborn Errors Ammonia Argininosuccinic Aciduria Carbamoyl-Phosphate Synthase (Ammonia)Diagnosis, Differential Humans Infant, Newborn Infant, Premature, Diseases Metabolism, Inborn Errors Ornithine Carbamoyltransferase Deficiency Disease Urea English Abstract Journal Article Research Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

J Jaeken, H Devlieger, M Evens, P Casaer, E Eggermont. 1983. [Neonatal hyperammonemia].. https://pubmed.ncbi.nlm.nih.gov/6636106/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1996

Histological improvement in native liver after auxiliary partial liver transplantation for ornithine transcarbamylase deficiency.

Explore the source record for details and available documents.

Amino Acid Metabolism, Inborn Errors↗

PubMed1996

The human plasmalemmal carnitine transporter defect is expressed in cultured lymphoblasts: a new non-invasive method for diagnosis.

Explore the source record for details and available documents.

Amino Acid Metabolism, Inborn Errors↗

PubMed1996

Prenatal monitoring in a family at high risk for ornithine transcarbamylase (OTC) deficiency: a new mutation of an A-to-C transversion in position +4 of intron 1 of the OTC gene that is likely to abolish enzyme activity.

DNA analysis of a male propositus with ornithine transcarbamylase (OTC) deficiency documented an A-to-C substitution in position +4 of intron 1. No other abnormalities were observed in the OTC gene, or at 563 bp upstream of the 5' site, which included a promoter region, or at 383 bp downstream of the termination codon, which included a polyadenylation signal sequence. This mutation produces an RsaI site in the sequence, which was used for prenatal monitoring in the fourth and fifth pregnancies. DNA from amniotic cells in the former case were positive for RsaI digestion and the SRY gene (sex determinant region Y), indicating hemizygosity for the mutant allele. OTC activity was not measurable, and mRNA of the OTC gene was not detected by Northern blotting in the affected fetal liver. RT-PCR (reverse transcription-PCR) demonstrated only the wild-type allele. Thus, the mutation interferes with RNA processing, and an extremely low amount of normally spliced mRNA for the OTC gene seems to have caused the disease in our patient. The fetus of the fifth pregnancy was a normal male, as confirmed postnatally.

Amino Acid Metabolism, Inborn Errors↗